⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18627065 | 1.00 | — | — | |
| SCHEMBL15507551 | 1.00 | — | — | |
| SCHEMBL24892915 | 1.00 | — | — | |
| SCHEMBL22326406 | 0.79 | — | — | |
| SCHEMBL22644741 | 0.79 | — | — | |
| SCHEMBL1550554 | 0.79 | — | — | |
| SCHEMBL21091340 | 0.79 | — | — | |
| SCHEMBL14685711 | 0.79 | — | — | |
| SCHEMBL19156018 | 0.79 | — | — | |
| Hydrochloric Acid SCHEMBL6360428 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2019014315-A1 | RAD51 INHIBITORS | CYTEIR THERAPEUTICS, INC. (US) | 2019-01-17 | — | — | WO | disclosed |